ImmuPharma's market cap is currently £19.16M. The company's EPS TTM is p; its P/E ratio is ―; ImmuPharma is scheduled to report earnings on May 22, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 0.00	£ 0.00	£ 118.35K	£ 126.67K	£ 77.92K
Gross Profit	£ -37.61K	£ -117.56K	£ 118.35K	£ 126.67K	£ 77.92K
Operating Income	£ -3.06M	£ -3.03M	£ -6.59M	£ -5.59M	£ -6.28M
EBITDA	£ -3.03M	£ -2.91M	£ -8.70M	£ -6.84M	£ -6.65M
Net Income	£ -2.92M	£ -3.81M	£ -8.17M	£ -6.86M	£ -6.12M
Balance Sheet
Cash & Short-Term Investments	£ 208.48K	£ 667.81K	£ 1.65M	£ 5.86M	£ 1.36M
Total Assets	£ 2.72M	£ 3.97M	£ 6.00M	£ 10.92M	£ 5.80M
Total Debt	£ 0.00	£ 111.00	£ 700.00	£ 641.84K	£ 26.78K
Net Debt	£ -208.48K	£ -667.70K	£ -1.65M	£ -5.22M	£ -1.34M
Total Liabilities	£ 1.67M	£ 1.45M	£ 1.58M	£ 1.26M	£ 531.87K
Stockholders' Equity	£ 1.06M	£ 2.52M	£ 4.41M	£ 9.65M	£ 5.27M
Cash Flow
Free Cash Flow	£ -1.36M	£ -2.45M	£ -4.88M	£ -3.69M	£ -4.33M
Operating Cash Flow	£ -1.36M	£ -2.35M	£ -4.83M	£ -3.33M	£ -4.22M
Investing Cash Flow	£ 188.76K	£ -77.42K	£ -50.28K	£ -569.20K	£ -101.37K
Financing Cash Flow	£ 722.10K	£ 1.55M	£ 702.05K	£ 8.37M	£ 325.71K

Currency in GBP

ImmuPharma Earnings and Revenue History

Income Statement >

ImmuPharma Debt to Assets

Balance Sheet >

ImmuPharma Cash Flow

Cash Flow >

ImmuPharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing